Matches in Wikidata for { <http://www.wikidata.org/entity/Q64349288> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64349288 description "clinical trial" @default.
- Q64349288 description "ensayu clínicu" @default.
- Q64349288 description "klinisch onderzoek" @default.
- Q64349288 description "клінічне випробування" @default.
- Q64349288 name "Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma" @default.
- Q64349288 type Item @default.
- Q64349288 label "Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma" @default.
- Q64349288 prefLabel "Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma" @default.
- Q64349288 P1050 Q64349288-C715522B-808C-475A-99A9-05B09F21A25A @default.
- Q64349288 P1132 Q64349288-CA7FCDBE-95CB-4A8A-969C-5878E9B67CF2 @default.
- Q64349288 P1476 Q64349288-A7022A70-B940-4CFB-B7B9-9DE1F02B4700 @default.
- Q64349288 P17 Q64349288-12BBD088-BFB9-4DE4-BAF8-1DF004BEC52F @default.
- Q64349288 P17 Q64349288-3F9072E1-1087-4DED-A247-DB81D18A5829 @default.
- Q64349288 P17 Q64349288-48CFDD3C-8028-4BF2-B10D-FD7E5001BE23 @default.
- Q64349288 P17 Q64349288-4D9F8F98-733E-47B9-A5EA-123A4D437A35 @default.
- Q64349288 P2899 Q64349288-79A68E0F-8C11-48BA-9E74-1ED4EEF38456 @default.
- Q64349288 P3098 Q64349288-9852A34D-3354-4841-8A1E-D77240EBDF8B @default.
- Q64349288 P31 Q64349288-D3E5D02B-367B-447A-9B6C-DD3AC813E4B2 @default.
- Q64349288 P4844 Q64349288-7350C22C-F4EF-41C9-8AF6-27763215426E @default.
- Q64349288 P4844 Q64349288-D0BFEA7A-B9DE-4C9A-B6C3-CD77BE7DA118 @default.
- Q64349288 P580 Q64349288-45CA521B-CE6E-4D24-987F-1623480A1E43 @default.
- Q64349288 P582 Q64349288-43F5EAAB-44E7-4AB9-B537-11116608F8D8 @default.
- Q64349288 P6099 Q64349288-D169B33F-9FB5-49B7-BDC8-ECDF130547A6 @default.
- Q64349288 P6153 Q64349288-4C9D8A3D-9612-4E9C-B593-666AFF1D9DB0 @default.
- Q64349288 P6153 Q64349288-4D1F6CE2-7E8B-43D8-A9F4-8817383311A7 @default.
- Q64349288 P6153 Q64349288-52959CAF-F6E0-4989-AD46-8CC6B8F9C98A @default.
- Q64349288 P6153 Q64349288-73F4A87A-69C7-4C40-BB0C-5527407928DF @default.
- Q64349288 P6153 Q64349288-7EF33AA4-B95B-482B-9AF3-EDA5F0023248 @default.
- Q64349288 P6153 Q64349288-88E39AE8-FBC3-4770-B447-2DBAF039AA92 @default.
- Q64349288 P6153 Q64349288-B32BF9B0-DC7A-4737-B070-B526CF77F601 @default.
- Q64349288 P6153 Q64349288-D4B58E94-A88B-4537-84DD-BCA425623DE5 @default.
- Q64349288 P6153 Q64349288-E530E870-3209-4268-A8C0-4D94AC827981 @default.
- Q64349288 P8363 Q64349288-1CB0F7E4-E2E7-4A2B-AA1C-6FA8B6A8F697 @default.
- Q64349288 P1050 Q208414 @default.
- Q64349288 P1132 "+174" @default.
- Q64349288 P1476 "A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma." @default.
- Q64349288 P17 Q142 @default.
- Q64349288 P17 Q16 @default.
- Q64349288 P17 Q30 @default.
- Q64349288 P17 Q38 @default.
- Q64349288 P2899 "+18" @default.
- Q64349288 P3098 "NCT02031419" @default.
- Q64349288 P31 Q30612 @default.
- Q64349288 P4844 Q412323 @default.
- Q64349288 P4844 Q425681 @default.
- Q64349288 P580 "2013-12-18T00:00:00Z" @default.
- Q64349288 P582 "2019-12-15T00:00:00Z" @default.
- Q64349288 P6099 Q5452194 @default.
- Q64349288 P6153 Q1130172 @default.
- Q64349288 P6153 Q17066381 @default.
- Q64349288 P6153 Q266227 @default.
- Q64349288 P6153 Q2944832 @default.
- Q64349288 P6153 Q30270369 @default.
- Q64349288 P6153 Q3803602 @default.
- Q64349288 P6153 Q43896526 @default.
- Q64349288 P6153 Q5188247 @default.
- Q64349288 P6153 Q838330 @default.
- Q64349288 P8363 Q78089383 @default.